Search - tctmd.com

Displaying 321 - 338 of 338

Sort: Relevancy | Date

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Yael L. Maxwell

June 20, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

PRODIGY Published: No Advantage to Long-term Clopidogrel

April 03, 2012

News Conference News ACC 2012

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Jason Kahn

March 24, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Conference News

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

August 30, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

Jason Kahn

May 05, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

L.A. McKeown

January 03, 2011

Advertisement

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

Signs Point to Relationship Between Clopidogrel Efficacy, Cigarette Smoking

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

PRODIGY Published: No Advantage to Long-term Clopidogrel

Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES

Statins Reduce Late Restenosis After SES Implantation

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

High-dose Statins Reduce CIN in ACS Patients Receiving PCI

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content